Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : JADO INITIATES PHASE II TRIALS OF LEAD RAFT MODULATOR IN URTICARIA - PR Inside

JADO INITIATES PHASE II TRIALS OF LEAD RAFT MODULATOR IN URTICARIA - PR Inside

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service63 times read : Adjust font size: Decrease font Enlarge font
image

2008-07-02 10:58:45 - Dresden, Germany, July 2, 2008 -- JADO Technologies GmbH, the leading developer of RAFT intervention therapeutics, announced today the start of a Phase II study to evaluate the safety and efficacy of oral TF002, a formulation of ...

Read this article...



Post your comment comment Comments (0 posted)

copyright